Not applicableWithdrawnNCT06692153What this trial is testingEmbecta AID System in Adults With Type 2 DiabetesWho this might be right forType 2 DiabetesType 2 Diabetes Mellitus (T2DM)Type 2 DM+4 more Embecta Corp.
Large-scale testing (Phase 3)Ended earlyNCT03608358What this trial is testingSafety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/SaxagliptinWho this might be right forType 2 Diabetes Mellitus AstraZeneca 41
Large-scale testing (Phase 3)Ended earlyNCT01678820What this trial is testingThe Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 299
Large-scale testing (Phase 3)Study completedNCT00960076What this trial is testingAn 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 DiabetesWho this might be right forType 2 Diabetes AstraZeneca 282
Large-scale testing (Phase 3)Study completedNCT02226003What this trial is testingEfficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 291
Large-scale testing (Phase 3)Study completedNCT05814406What this trial is testingTo Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DMWho this might be right forType 2 Diabetes Mellitus JW Pharmaceutical 196
Testing effectiveness (Phase 2)Study completedNCT03317028What this trial is testingCS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)Who this might be right forT2DM With Inadequate Glycemic Control Center Laboratories, Inc. 201
Large-scale testing (Phase 3)Study completedNCT02099110What this trial is testingErtugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 1,233
Early research (Phase 1)Study completedNCT00704132What this trial is testingSitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)Who this might be right forType 2 Diabetes Mellitus (T2DM) Merck Sharp & Dohme LLC 57
Post-approval studies (Phase 4)Study completedNCT00833027What this trial is testingALPHA Sitagliptin Add on to Metformin (0431-103)Who this might be right forDiabetes Mellitus Merck Sharp & Dohme LLC 608
Post-approval studies (Phase 4)Study completedNCT02025907What this trial is testingEvaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and SitagliptinWho this might be right forDiabetes Mellitus, Type 2 Janssen Research & Development, LLC 218
Large-scale testing (Phase 3)Ended earlyNCT04754334What this trial is testingEvaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes MellitusWho this might be right forT2DM (Type 2 Diabetes Mellitus) Oramed, Ltd. 346
Large-scale testing (Phase 3)Looking for participantsNCT07743983What this trial is testingBGM0504 in Early T2DM With ObesityWho this might be right forType 2 Diabetes (T2DM) BrightGene Bio-Medical Technology Co., Ltd. 372
Large-scale testing (Phase 3)Study completedNCT01177384What this trial is testingClinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 380
Testing effectiveness (Phase 2)Looking for participantsNCT07109700What this trial is testingHDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or MetforminWho this might be right forType 2 Diabetes Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 216
Early research (Phase 1)Study completedNCT00511108What this trial is testingSitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)Who this might be right forType 2 Diabetes Mellitus (T2DM) Merck Sharp & Dohme LLC 211
Large-scale testing (Phase 3)Study completedNCT04634500What this trial is testingThe Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.Who this might be right forT2DM (Type 2 Diabetes Mellitus) Daewoong Pharmaceutical Co. LTD. 200
Large-scale testing (Phase 3)Looking for participantsNCT07394114What this trial is testingHDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise AloneWho this might be right forType 2 Diabetes Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 240
Large-scale testing (Phase 3)Study completedNCT02532855What this trial is testingAssess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 614
Large-scale testing (Phase 3)Study completedNCT01999218What this trial is testingErtugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 1,326